Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective

Breast Cancer Research and Treatment

Volumn 98, Issue 3, 2006, Pages 343-348

  Hurria, Arti ^a   Goldfarb, Shari ^b   Rosen, Carol ^b   Holland, Jimmie ^a   Zuckerman, Enid ^a   Lachs, Mark S ^c   Witmer, Matthew ^a   Van Gorp, Wilfred G ^d   Fornier, Monica ^a   D'Andrea, Gabriella ^a   Moasser, Mark ^e   Dang, Chau ^a   Van Poznak, Catherine ^a   Robson, Mark ^a   Currie, Violante E ^a   Theodoulou, Maria ^a   Norton, Larry ^a   Hudis, Clifford ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d College of Physicians and Surgeons ^*  (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adjuvant chemotherapy; Cognitive function; Memory; Neuropsychological

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TRASTUZUMAB;

AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; FEMALE; HIGH RISK POPULATION; HUMAN; LEARNING; MEMORY DISORDER; PRIORITY JOURNAL; QUESTIONNAIRE; SQUIRE MEMORY SELF RATING QUESTIONNAIRE; WORKING MEMORY;

AGED; AGED, 80 AND OVER; AGING; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COGNITION; FEMALE; HUMANS; MEMORY;

EID: 33746866643     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9171-6     Document Type: Article

References (15)

1. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472): 1687-1717, 2005
2. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA: The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100: 2292-2299, 2004
3. Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, Whedon MB, Bivens S, Mitchell T, Greenberg ER, Silberfarb PM: Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20: 485-493, 2002
4. Brezden CB, Phillips K, Abdolell M, Bunson T, Tannock IF: Cognitive function in breast cancer patients receiving adjuvant chemotherapy. JCO 18(14): 2695-2701, 2000
5. Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Brunning PF: Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85(3): 640-650, 1999
6. Van Dam FSAM, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, Rodenhuis S: Impairment of cognitive function in women receiving adjuvant treatment for high risk breast cancer: high dose versus standard dose chemotherapy. J Natl Cancer Inst 90(3): 210-218, 1998
7. Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D: The effects of adjuvant chemotherapy on cognition in women with breast cancer - preliminary results of an observation longitudinal study. The Breast 14: 142-150, 2005
8. Squire LR, Wetzel CD, Slater PC: Memory complaints after electroconvulsive therapy: assessment with a new self-rating instrument. Biol Psychiatry 14(5): 791-801, 1979
9. Fried TR, Bradley EH, Towle VR, Allore H: Understanding the treatment preferences of seriously ill patients. N Engl J Med 346: 1061-6, 2002
10. Yellen SB, Cella DF, Leslie WT: Age and clinical decision making in oncology patients. J Natl Cancer Inst 86: 1766-70, 1994
11. Eagles JM, Beattie JAG, Restall DB, Rawlinson F, Hagen S, Ashcroft GW: Relationship between cognitive impairment and early death in the elderly. Br Med J 300: 239-240, 1990
12. Wolfson C, Wolfson DB, Asgharian M, M'Lan CE, Ostbye T, Rockwood K, Hogan DB: A reevaluation of the duration of survival after the onset of dementia. New Engl J Med 344: 1111-16, 2001
13. Saykin AJ, Janssen R, Sprehn GC, Kaplan JE, Spira TJ, O'Connor B: Longitudinal evaluation of neuropsychological function in homosexual men with HIV-1 infection: 18 month follow-up. J Neuropsychiatry Clin Neurosci 3: 286-298, 1991
14. Deutsch GK, Saykin AJ, Sperling MR: Metamemory in temporal lobe epilepsy assessment 3: 255-263, 1996
15. McAllister TW, Flashman LA, SparlingMB, Saykin AJ, Ferguson R, Yanofsky N: Relationship of psychopathology to post-concussive symptoms one month after mild traumatic brain injury. J Neuropsychiatry Clin Neurosci 11: 150-151, 1999